AbstractAppropriate antimicrobial therapy is effective for severe infections caused by Acinetobacter baumannii, but efficacy for other Acinetobacter species remains to be established. The current study was designed to determine whether appropriate antimicrobial therapy reduces the mortality of patients with Acinetobacter nosocomialis bacteraemia. A 9-year retrospective study of 266 patients with monomicrobial A. nosocomialis bacteraemia was conducted at a large teaching hospital in Taiwan. Multivariable analysis was performed to evaluate the impact on 14-day mortality according to clinical characteristics, severity of disease and use of appropriate antimicrobial therapy. The influence of APACHE II score on the impact of appropriate antimicr...
ABSTRACTObjective: Nosocomial infections or Hospital acquired infection (HAI) are one of the major t...
AbstractAcinetobacter baumannii is an important cause of nosocomial infections in many hospitals. It...
Abstract\ud \ud Background\ud It has been challenging ...
[[abstract]]Appropriate antimicrobial therapy is effective for severe infections caused by Acinetoba...
[[abstract]]Background. The efficacy of antimicrobial therapy for Acinetobacter baumannii bacteremia...
[[abstract]]BACKGROUND: The impact of appropriate antimicrobial therapy for A. baumannii bacteremic ...
AbstractThe clinical characteristics and risk factors for 28-day mortality in 120 patients with soli...
AbstractThe phenotypically indistinguishable Acinetobacter baumannii and Acinetobacter nosocomialis ...
The objectives were to analyze treatment, clinical outcomes, and predictors of mortality in hospital...
Infections by Acinetobacter species are recognized as a serious global threat due to causing severe ...
BackgroundAcinetobacter baumannii has emerged as an important pathogen of nosocomial infection. The ...
[[abstract]]AbstractBackground/Purpose Patients with Acinetobacter pittii and A. nosocomialis bacter...
The purpose of this investigation was to compare the efficacy of colistin-based therapies in extreme...
Abstract. Acinetobacter spp is a known nosocomial pathogen causing a wide range of clinical diseases...
Objectives: The incidence of Acinetobacter baumannii pathogen is high especially among patients hosp...
ABSTRACTObjective: Nosocomial infections or Hospital acquired infection (HAI) are one of the major t...
AbstractAcinetobacter baumannii is an important cause of nosocomial infections in many hospitals. It...
Abstract\ud \ud Background\ud It has been challenging ...
[[abstract]]Appropriate antimicrobial therapy is effective for severe infections caused by Acinetoba...
[[abstract]]Background. The efficacy of antimicrobial therapy for Acinetobacter baumannii bacteremia...
[[abstract]]BACKGROUND: The impact of appropriate antimicrobial therapy for A. baumannii bacteremic ...
AbstractThe clinical characteristics and risk factors for 28-day mortality in 120 patients with soli...
AbstractThe phenotypically indistinguishable Acinetobacter baumannii and Acinetobacter nosocomialis ...
The objectives were to analyze treatment, clinical outcomes, and predictors of mortality in hospital...
Infections by Acinetobacter species are recognized as a serious global threat due to causing severe ...
BackgroundAcinetobacter baumannii has emerged as an important pathogen of nosocomial infection. The ...
[[abstract]]AbstractBackground/Purpose Patients with Acinetobacter pittii and A. nosocomialis bacter...
The purpose of this investigation was to compare the efficacy of colistin-based therapies in extreme...
Abstract. Acinetobacter spp is a known nosocomial pathogen causing a wide range of clinical diseases...
Objectives: The incidence of Acinetobacter baumannii pathogen is high especially among patients hosp...
ABSTRACTObjective: Nosocomial infections or Hospital acquired infection (HAI) are one of the major t...
AbstractAcinetobacter baumannii is an important cause of nosocomial infections in many hospitals. It...
Abstract\ud \ud Background\ud It has been challenging ...